Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient miceVALENTA, David T; BULGRIEN, Joshua J; BANKA, Carole L et al.Atherosclerosis. 2006, Vol 189, Num 2, pp 255-263, issn 0021-9150, 9 p.Article

Polymer particle shape independently influences binding and internalization by macrophagesSHARMA, Gaurav; VALENTA, David T; ALTMAN, Yoav et al.Journal of controlled release. 2010, Vol 147, Num 3, pp 408-412, issn 0168-3659, 5 p.Article

Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpressionVALENTA, David T; OGIER, Nicolas; BRADSHAW, Gary et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 7, pp 1572-1578, issn 1079-5642, 7 p.Article

What is so special about apolipoprotein AI in reverse cholesterol transport?CURTISS, Linda K; VALENTA, David T; HIME, Neil J et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 1, pp 12-19, issn 1079-5642, 8 p.Article